First Patient Gets Implantable Telescope

The first patient has received the FDA-approved implantable miniature telescope for the treatment of end-stage age-related macular degeneration (AMD), according to a press release from CenteraSigh. The first patient's ophthalmologists were Henry L. Hudson, M.D., retinal specialist at Retina Centers, P.C., and Kristin Carter, M.D., anterior segment eye surgeon, both part of the CentraSigh provider team in Tucson. The procedure was performed on an outpatient basis at Carondelet Health Network's St. Joseph's Hospital in Tucson. It launches VisionCare's CentraSight AMD treatment program, which utilizes the implant for treating patients with advanced forms and stages of AMD. Read more.